Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate added to bupivacaine for caudal anesthesia in pediatric inguinal hernia repair
IRCT20221126056613N1Phase 2Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of bupivacaine and magnesium sulfate in inguinal hernia (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoint: Pain measurement. Started Jan 2023; status: completed.
02
Drugs
bupivacainemagnesium sulfate
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on IRCT20221126056613N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221126056613N1.